
    
      The primary study objectives are:

        -  To assess the tolerability and safety of the Influenza VLP Vaccine

        -  To assess the immunogenicity of the Influenza VLP Vaccine as measured by
           hemagglutination inhibition (HAI) antibody titers to each of the component viral strains
    
  